Clinuvel Pharmaceuticals reported AUD35.2M in Cash and Equivalent for its fiscal semester ending in June of 2024.





Cash And Equivalent Change Date
Avita Medical AUD 10.24M 1.98M Dec/2025
Medical Developments International AUD 17.84M 219K Jun/2025
Mesoblast USD 129.57M 31.58M Dec/2025
Neuren Pharmaceuticals AUD 4.23M 1.68M Dec/2025
Pacific Edge NZD 29.26M 8.79M Jun/2024
Paradigm Biopharmaceuticals AUD 16.82M 1M Jun/2025
PYC Therapeutics AUD 153.05M 103.8M Jun/2025
Telix Pharmaceuticals AUD 141.87M 65.29M Dec/2025